Skip to content

H2020FP7HORIZON

Academisch Ziekenhuis Leiden

Country
NLNetherlands
Defence projects
0
Projects, all programmes
336
As coordinator
102
EU contribution (CORDIS)
EUR 216,538,375
Active
2008 to 2026

Projects

336 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
OptiMalVaxOptimizing a deployable high efficacy malaria vaccineH20202017ParticipantEUR 1,179,726
Bio-ICDBiological auto-detection and termination of heart rhythm disturbancesH20202017CoordinatorEUR 1,485,028
COMBACTE-CDICombatting Bacterial Resistance in Europe - Clostridium Difficile InfectionsH20202017ParticipantEUR 137,676
EN_ACTI2NGEuropean Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale GeometryH20202017ParticipantEUR 255,374
A4BAnalytics for BiologicsH20202017ParticipantEUR 510,749
EOSCpilotThe European Open Science Cloud for Research Pilot Project.H20202017ParticipantEUR 12,025
OVO-GROWTHOogenesis spotlighted: making mature human oocytesH20202017CoordinatorEUR 2,000,000
SoraprazanSoraprazan - a new regenerative therapy for Stargardt's diseaseH20202017ParticipantEUR 178,223
GeroProtectDeveloping Geroprotectors to Prevent PolymorbidityH20202017ParticipantEUR 281,250
LEaDing FellowsLEaDing FellowsH20202017PartnerEUR 0
AUTOCOMPLEMENTThe role of complement in the induction of autoimmunity against post-translationally modified proteinsH20202017CoordinatorEUR 1,999,803
IMGENEImproving Genome Editing Efficiency (IMGENE)H20202017ParticipantEUR 255,374
RTCureRheuma Tolerance for CureH20202017ParticipantEUR 573,175
DNAREPAIRMANRegulated Assembly of Molecular Machines for DNA REPAIR: a Molecular Analysis training NetworkH20202017ParticipantEUR 255,374
ARREST BLINDNESSAdvanced Regenerative and REStorative Therapies to combat corneal BLINDNESSH20202016ParticipantEUR 80,500
TECHNOBEATTools and TECHNOlogies for Breakthrough in hEArt TherapiesH20202016ParticipantEUR 649,750
ISPICImage-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer OutcomeH20202016ParticipantEUR 680,998
SCIDNETDevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID)H20202016ParticipantEUR 799,877
UM Cure 2020New therapies for uveal melanomaH20202016ParticipantEUR 1,109,040
POWER2DMPOWER2DM - Predictive model-based decision support for diabetes patient empowermentH20202016ParticipantEUR 888,239

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.